Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Doleyka
- Development stage
- Unknown
- Lead developer
- Evolet Healthcare
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Doleyka is a plant-based oral syrup formulated as a multi-herb complex for the treatment and prevention of helminthic (parasitic) infections, particularly in pediatric populations. It contains a unique combination of 11 traditional herbs, including Vaibidang (*Embelia ribes*), Palash (*Butea monosperma*), Kutki (*Picrorrhiza kurroa*), Nagarmotha (*Cyperus scariosus*), Ajmoda (*Apium graveolens*), Tulsi (*Ocimum basilicum*), Chirayata (*Swertia chirayata*), Kalajeera (*Carum carvi*), Kutaj (*Holarrhena antidysenterica*), Dikamali (*Gardenia gummifera*), and Anar chilka (*Punica granatum*). Doleyka exhibits anthelmintic, antimicrobial, antiseptic, antidiarrheal, and astringent properties, while also improving digestion and intestinal peristalsis. It is designed to eliminate parasites, reduce the likelihood of re-occurrence of parasite eggs and cysts in the gut, and alleviate associated symptoms such as spastic syndrome, nausea, and toxicity induced by helminthic invasion.
- Brand names
- Doleyka
Beyond the preview
Go deeper on Doleyka.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Doleyka.